<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate in adults with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> the extent to which the relation of <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> (LVH) to markers of systemic <z:mp ids='MP_0001845'>inflammation</z:mp> (fibrinogen and high-sensitivity C-reactive protein [hsCRP]) are affected by <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We selected adults with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> using American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association criteria from a population-based cohort, excluding those with medical history or electrocardiographic evidence of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> or dialysis-dependent <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>LVH was assessed by echocardiogram </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of the 1299 eligible participants, 384 (29.6%) had LVH, which was associated with higher BMI, hsCRP, fibrinogen, and <z:mp ids='MP_0002871'>albuminuria</z:mp> in univariate analyses </plain></SENT>
<SENT sid="4" pm="."><plain>After controlling for significant confounders, fibrinogen and <z:mp ids='MP_0002871'>albuminuria</z:mp> were higher in the presence of LVH (both P &lt; 0.01), whereas hsCRP was not (P = 0.2), mostly because of the confounding effect of BMI </plain></SENT>
<SENT sid="5" pm="."><plain>Adjustment for <z:mp ids='MP_0002871'>albuminuria</z:mp> abolished the relation of LVH to higher fibrinogen (P = 0.2) </plain></SENT>
<SENT sid="6" pm="."><plain>However, fibrinogen was significantly higher in participants with LVH among those without pathologic levels of <z:mp ids='MP_0002871'>albuminuria</z:mp> (&lt;30 mg/g creatinuria), but not independent of BMI </plain></SENT>
<SENT sid="7" pm="."><plain>Although hsCRP and fibrinogen were moderately correlated, fibrinogen, but not CRP, showed a significant relation with <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In adults with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, echocardiographic LVH is associated with susceptibility to atherothrombosis and increased <z:mp ids='MP_0002871'>albuminuria</z:mp>, which is a marker of <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e> and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> that appears in turn to be a relevant pathogenetic link between LVH and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>However, in the absence of significant <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, elevated BMI is a relevant pathogenetic factor in the relation of LVH to increased levels of markers of <z:mp ids='MP_0001845'>inflammation</z:mp>, potentially preceding development of significant <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>In the presence of <z:e sem="disease" ids="C0155765" disease_type="Disease or Syndrome" abbrv="">microangiopathy</z:e>, we found that the atherothrombotic risk profile associated with LVH was independent of BMI and possibly reflected the association of LVH with a higher degree of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
</text></document>